Treatment Access Solution

A collaboration with Celgene Thailand

Pomalyst® (pomalidomide)

The Max Foundation partners with Celgene Thailand to increase access to Pomalyst® (pomalidomide) through the IMiDs Patient Assistance Program (I-PAP) for multiple myeloma patients in Thailand who meet the medical criteria and program guidelines.

Contact us for more information about how to access Pomalyst® for multiple myeloma patients in Thailand.

Return to Treatment Access Solutions

Go on the Patient Journey

Join Tony as he shares his story of learning about his cancer, gaining access to life-saving medication, and connecting with a community of care.
Follow Tony's Journey